Healthcare & Life Sciences
RyCarma Therapeutics
United Statesrycarma.com
RyCarma Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
2004
Founded
1
Investors
About RyCarma Therapeutics
Based in the United States, RyCarma Therapeutics is a startup founded in 2004. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
RyCarma Therapeutics is a clinical-stage biotech company developing first-in-class small molecule therapeutics, known as Rycals, for cardiovascular and skeletal muscle diseases by targeting ryanodine receptor (RyR) calcium channels.
Explore RyCarma Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.